Evidence-based guidance for diagnostic laboratories to make an informed decision on choices of commercial assay for carbapenemase detection. Category: UncategorisedBy 16 August 2021Leave a commentPost navigationPreviousPrevious post:Guidance: Best start in life and beyondNextNext post:Guidance: COVID-19: how to work safely in care homes
